| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $66.4M | +9.2% |
| Cost of Revenue | $44.7M | +2.5% |
| Gross Profit | $21.7M | +26.2% |
| R&D Expense | $4.5M | -9.2% |
| SG&A Expense | $22.3M | +17.8% |
| Operating Income | -$5.0M | +24.0% |
| Income Tax | $4K | +33.3% |
| Net Income | -$6.7M | +19.9% |
| EPS (Basic) | -$0.40 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | +107.5% |
| Accounts Receivable | $11.4M | +16.4% |
| Inventory | $17.2M | +1.5% |
| Current Assets | $31.8M | +12.2% |
| Total Assets | $34.8M | +7.6% |
| Current Liabilities | $39.6M | +29.2% |
| Total Liabilities | $40.2M | +25.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $610K | +112.7% |
| Capital Expenditures | $653K | -23.4% |
| Investing Cash Flow | -$653K | +23.4% |
| Financing Cash Flow | $734K | -81.3% |
| Free Cash Flow | -$43K | +99.2% |
| +20.0% |
| EPS (Diluted) | -$0.40 | +20.0% |
| Stockholders' Equity |
| -$5.4M |
| -2885.6% |